GM-CSF as a systemic adjuvant in a phase
β
Simmons, S.J.; Tjoa, B.A.; Rogers, M.; Elgamal, A.; Kenny, G.M.; Ragde, H.; Troy
π
Article
π
1999
π
John Wiley and Sons
π
English
β 125 KB
π 1 views
## BACKGROUND. Recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF; Leukine [sargramostim], Immunex Corp., Seattle, WA) was administered to a subgroup of 44 patients in a phase II clinical trial for prostate cancer using DC pulsed with HLA-A2-specific prostate-specific membr